Patients don’t think about documentation and logistics—but their care depends on them. Hospitals and travel programs succeed when the pharma side is quiet and predictable. This is how India keeps it that way.
From booking to bedside
- Source meds and devices with alternates
- Prepare clean documentation packets
- Select lanes with short dwell and tested handlers
- Align arrivals with treatment windows
| KPI | Top quartile | Median | Why it matters |
|---|---|---|---|
| OTIF for treatment kits | 95–97% | 92–94% | Fewer reschedules |
| Docs exceptions (per packet) | ≤2% | 3–5% | Less time at borders |
| Excursion resolution | <12h | 24–36h | Protects outcomes |
Choose lanes that keep promises
Export Performance by Region
1United States
$8.2B25% tariffHigh
2European Union
$6.8B0% tariffMedium
3Asia-Pacific
$4.5B5% tariffLow
4Middle East
$2.1B0% tariffMedium
5Africa
$1.8B0% tariffLow
EU lanes: quick with clean docs. US lanes: heavier checks—start early. APAC/Middle East: buffers and alternates are your friend.
Packet discipline avoids drama
- Structured invoices, CoAs, and licences
- Chain-of-custody evidence
- Pre-clear API or manual pre-advice
- Escalation path and contact sheet
Teams that rehearse exception drills rarely need them. When they do, they resolve issues fast.
What patients and buyers really ask
| Question | Answer (plain) |
|---|---|
| Can we trust the cold chain? | Yes—monitored end-to-end with trained handlers; excursions are isolated and investigated. |
| What if border checks hold us? | We pre-clear and pay for shorter dwell where needed; alternates are ready. |
| How do you avoid last-minute scrambles? | Standard packets, validated fields, and rehearsed escalations keep surprises out of the plan. |